Spots Global Cancer Trial Database for myasthenia gravis
Every month we try and update this database with for myasthenia gravis cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Long Term Safety Study of Amifampridine Phosphate in MuSK-MG (Muscle Specific Tyrosine Kinase Myasthenia Gravis) | NCT03579966 | Myasthenia Grav... AChR Myasthenia... | Amifampridine P... | 18 Years - | Catalyst Pharmaceuticals, Inc. | |
| A Phase 3 Open-Label Study of Eculizumab in Pediatric Participants With Refractory Generalized Myasthenia Gravis (gMG) | NCT03759366 | Myasthenia Grav... Myasthenia Grav... Myasthenia Grav... | Eculizumab | 6 Years - 17 Years | Alexion Pharmaceuticals, Inc. | |
| Pharmacodynamic Study of CK-2017357 in Patients With Generalized Myasthenia Gravis | NCT01268280 | Myasthenia Grav... | Placebo 250 mg CK-20173... 500 mg CK-20173... | 18 Years - 80 Years | Cytokinetics | |
| A Study of TAK-079 in People With Generalized Myasthenia Gravis | NCT04159805 | Myasthenia Grav... | TAK-079 TAK-079 Placebo | 18 Years - | Takeda | |
| A Study to Compare the Efficacy and Safety of Tacrolimus Capsules in Patient With Myasthenia Gravis | NCT01325571 | Myasthenia Grav... | Tacrolimus caps... Placebo | 18 Years - 70 Years | Astellas Pharma Inc | |
| Influences of Sugammadex on Postoperative Progress in Patients With Myasthenia Gravis Undergoing Video-assisted Thoracoscopic Thymectomy: Retrospective Study | NCT05694234 | Myasthenia Grav... | 19 Years - | Yonsei University | ||
| Exercise for Stable Myasthenia Gravis | NCT01047761 | Myasthenia Grav... | Exercise | 18 Years - 70 Years | Baltimore VA Medical Center | |
| Myasthenia Gravis Inebilizumab Trial | NCT04524273 | Myasthenia Grav... | inebilizumab IV Placebo | 18 Years - | Amgen | |
| Study of Myasthenic Crisis in China | NCT04837625 | Myasthenia Grav... Myasthenic Cris... | no intervention... | 18 Years - | Huashan Hospital | |
| A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa | NCT06298565 | Myasthenia Grav... | efgartigimod | 18 Years - | argenx | |
| Vitaccess Real MG Registry | NCT06064461 | Myasthenia Grav... | 18 Years - | Vitaccess Ltd | ||
| Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study) | NCT01997229 | Refractory Gene... | Eculizumab Placebo | 18 Years - | Alexion Pharmaceuticals, Inc. | |
| Physical Activity Monitoring in Myasthenia Gravis | NCT06277830 | Myasthenia Grav... | Wearable sensor | 18 Years - 80 Years | Massachusetts General Hospital | |
| Myasthenia Gravis and Psyche | NCT03205306 | Myasthenia Grav... | 18 Years - | Charite University, Berlin, Germany | ||
| Safety, Tolerability and Immunogenic Response of CV-MG01 in Patients With Myasthenia Gravis | NCT02609022 | Myasthenia Grav... | CV-MG01 Placebo | 18 Years - 64 Years | CuraVac | |
| Thymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone Therapy | NCT00294658 | Myasthenia Grav... | thymectomy plus... prednisone alon... | 18 Years - 65 Years | University of Alabama at Birmingham | |
| Hematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia Gravis | NCT00424489 | Myasthenia Grav... | Hematopoietic S... Cyclophosphamid... ATG (rabbit) Mesna Methylprednisol... G-CSF | 15 Years - 65 Years | Northwestern University | |
| Exploring Outcomes and Characteristics of Myasthenia Gravis 2 | NCT06002945 | Myasthenia Grav... | Blood sample | 18 Years - | Yale University | |
| Tissue Repository for Studies of Myasthenia Gravis | NCT02902536 | Myasthenia Grav... | No intervention... | 18 Years - | Johns Hopkins University | |
| Medlink for Diagnosing of Diabetes Mellitus, COPD, CHF, Myasthenia Gravis and Hypertension | NCT06256172 | Diabetes Mellit... Chronic Obstruc... Congestive Hear... Myasthenia Grav... Hypertension | Medlink | - | Olawuyi Racett Nigeria Ltd | |
| A Study of RVT-1401 in Myasthenia Gravis (MG) Patients | NCT03863080 | Myasthenia Grav... | RVT-1401 Placebo | 18 Years - | Immunovant Sciences GmbH | |
| Trial of Orencia in Patients With Myasthenia Gravis | NCT03059888 | Myasthenia Grav... | Abatacept Injec... | 16 Years - 85 Years | Johns Hopkins University | |
| Univent Tube for Thoracoscopic Thymectomy in Myasthenic Patients | NCT06101407 | Myasthenia Grav... | 15 Years - 80 Years | Vietnam Military Medical University | ||
| Tissue Repository for Studies of Myasthenia Gravis | NCT02902536 | Myasthenia Grav... | No intervention... | 18 Years - | Johns Hopkins University | |
| Help Build an A.I. Model to Predict Myasthenia Gravis Symptom Patterns and Flares | NCT04590716 | Myasthenia Grav... | Data Collection | 18 Years - | doc.ai inc | |
| Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity | NCT03941184 | SCAD Addison Disease Ankylosing Spon... Antiphospholipi... Celiac Disease Crohn Disease Dermatomyositis Polymyositis Guillain-Barre ... Hepatitis, Auto... Graves Disease Hashimoto Thyro... Multiple Sclero... Myasthenia Grav... Pernicious Anem... Polymyalgia Rhe... Primary Biliary... Psoriasis Rheumatoid Arth... Systemic Sclero... Sjögren Syndrom... Systemic Lupus ... Takayasu Arteri... Type 1 Diabetes... Ulcerative Coli... Uveitis Vasculitis Vitiligo Raynaud | 18 Years - 110 Years | Mayo Clinic | ||
| Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis | NCT02100969 | Myasthenia Grav... | HIZENTRA ® | 18 Years - | University of Kansas Medical Center | |
| A Pilot Study of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Generalized Myasthenia Gravis | NCT01555580 | Myasthenia Grav... | Granulocyte-Mac... | 18 Years - 80 Years | Muscular Dystrophy Association | |
| Clinical Trial to Improve the Magnetic Levator Prosthesis | NCT03818204 | Blepharoptosis Ptosis, Eyelid Myasthenia Grav... Stroke Traumatic Brain... | Magnetic Levato... | 4 Years - | Massachusetts Eye and Ear Infirmary | |
| Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System | NCT04561557 | Autoimmune Dise... Autoimmune Dise... Neuromyelitis O... Myasthenia Grav... Chronic Inflamm... Idiopathic Infl... Multiple Sclero... Autoimmune Ence... Myelin Oligoden... POEMS Syndrome | CT103A cells Cyclophosphamid... | 18 Years - 75 Years | Tongji Hospital | |
| Diaphragm Thickness by Ultrasonography in Neurological Disorders | NCT05324176 | Guillain-Barre ... Myasthenia Grav... | diaphragmatic u... | 18 Years - | Mansoura University | |
| Study of ALXN2050 in Adult Participants With Generalized Myasthenia Gravis | NCT05218096 | Generalized Mya... Myasthenia Grav... | ALXN2050 Placebo | 18 Years - 130 Years | Alexion Pharmaceuticals, Inc. | |
| Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives | NCT05635266 | Age-Related Mac... Allergies Alpha-Gal Syndr... Alzheimer Disea... Amyloidosis Ankylosing Spon... Arthritis Alopecia Areata Asthma Atopic Dermatit... Autism Autoimmune Hepa... Behcet's Diseas... Beta-Thalassemi... Cancer Celiac Disease Kidney Diseases COPD Crohn Disease Cystic Fibrosis Diabetes Dravet Syndrome DMD Fibromyalgia Graves Disease Thyroid Disease... Hepatitis Hidradenitis Su... ITP Leukemia ALS Lupus or SLE Lymphoma Multiple Sclero... Myasthenia Grav... Heart Diseases Parkinson Disea... Pemphigus Vulga... Cirrhosis Psoriasis Schizophrenia Scleroderma Sickle Cell Dis... Stroke Ulcerative Coli... Vasculitis Vitiligo | Specimen sample | 18 Years - 85 Years | Sanguine Biosciences | |
| Clinical Trial to Improve the Magnetic Levator Prosthesis | NCT03818204 | Blepharoptosis Ptosis, Eyelid Myasthenia Grav... Stroke Traumatic Brain... | Magnetic Levato... | 4 Years - | Massachusetts Eye and Ear Infirmary | |
| Descriptive Analysis of Real-world Data Collected With ME&MGopen | NCT05566964 | Myasthenia Grav... | ME&MGopen smart... | 18 Years - | Ad scientiam | |
| A Study to Evaluate the Efficacy, Safety and PD and PK of HBM9161 in MG Patients | NCT04346888 | Myasthenia Grav... | HBM9161 Injecti... Placebos HBM9161 Injecti... | 18 Years - 99 Years | Harbour BioMed (Guangzhou) Co. Ltd. | |
| A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Subjects With Refractory Generalized Myasthenia Gravis | NCT06193889 | Myasthenia Grav... Generalized Mya... | KYV-101 Standard lympho... | 18 Years - 75 Years | Kyverna Therapeutics | |
| Study of ALXN2050 in Adult Participants With Generalized Myasthenia Gravis | NCT05218096 | Generalized Mya... Myasthenia Grav... | ALXN2050 Placebo | 18 Years - 130 Years | Alexion Pharmaceuticals, Inc. | |
| The Efficacy and Safety of Leflunomide or Azathioprine Therapy in Myasthenia Gravis Patients After Expand Thymectomy | NCT01727193 | Myasthenia Grav... | Azathioprine Leflunomide | 12 Years - 65 Years | First Affiliated Hospital, Sun Yat-Sen University | |
| Beta-agonist Efficacy and Tolerability as Adjuvant Therapy in Myasthenia Gravis | NCT03914638 | Myasthenia Grav... | Salbutamol 4Mg ... Placebo oral ca... | 18 Years - | University of Aarhus | |
| Trial of Mycophenolic Acid Versus Azathioprine in the Treatment of Corticosteroid-refractory Myasthenia Gravis | NCT00997412 | Myasthenia Grav... | Mycophenolic ac... AZA | 20 Years - 70 Years | Qualitix Clinical Research Co., Ltd. | |
| Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases | NCT00716066 | Autoimmune Dise... Neurologic Auto... Autologous Tran... Multiple Sclero... MS Stem Cell Tr... Multiple Sclero... Stiff Person Sy... HCT for Neurolo... CIDP Transplant Myasthenia Grav... Autoimmune Nerv... Central Nervous... Cerebellar Dege... Chronic Inflamm... Lambert Eaton M... Myasthenia Grav... Neuromyelitis O... Opsoclonus Myoc... Rasmussen Subac... | Anti-Thymocyte ... Autologous Hema... Carmustine Cytarabine Etoposide Laboratory Biom... Melphalan Peripheral Bloo... Prednisone Syngeneic Bone ... | - 71 Years | Fred Hutchinson Cancer Center | |
| The Adapting Disease Specific Outcome Measures Pilot Trial for Telehealth in Myasthenia Gravis | NCT05917184 | Myasthenia Grav... | Telehealth | 18 Years - | Yale University | |
| A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis | NCT04951622 | Myasthenia Grav... | Nipocalimab Placebo | 18 Years - | Janssen Research & Development, LLC | |
| The Effect of Spinal Stabilization Exercises in Patients With Myasthenia Gravis | NCT03743740 | Myasthenia Grav... | Spinal stabiliz... | 18 Years - 65 Years | Hacettepe University | |
| Therapeutic Plasma Exchange in MG | NCT01927692 | Myasthenia Grav... | Skin biopsy Single Fiber El... | 18 Years - | Duke University | |
| Medication Adherence and Non-adherence in Adults With Rare Disease | NCT04541875 | Cystic Fibrosis Hemophilia A Hemophilia B Idiopathic Pulm... Myasthenia Grav... Sickle Cell Dis... | MAR-Scale | 18 Years - | Xperiome | |
| Safety, Tolerability and Immunogenic Response of CV-MG01 in Patients With Myasthenia Gravis | NCT02609022 | Myasthenia Grav... | CV-MG01 Placebo | 18 Years - 64 Years | CuraVac | |
| Biomarkers in Neural Disorders | NCT02761707 | Parkinson's Dis... Alzheimer's Dis... Progressive Sup... Essential Tremo... Multiple System... Drug Induced Pa... Diffuse Lewy Bo... Myasthenia Grav... Spinal Cord Inj... | Electrical Brai... Olfactory Tests Visual Deprivat... Peripheral Nerv... | 18 Years - 80 Years | University of Pennsylvania | |
| Study of Pyridostigmine With Ondansetron in Subjects With Anti-AchR Positive Myasthenia Gravis | NCT04226170 | Myasthenia Grav... | DAS-001 | 18 Years - | DAS-MG, Inc | |
| Vitaccess Real MG Registry | NCT06064461 | Myasthenia Grav... | 18 Years - | Vitaccess Ltd | ||
| Pharmacodynamic Study of CK-2017357 in Patients With Generalized Myasthenia Gravis | NCT01268280 | Myasthenia Grav... | Placebo 250 mg CK-20173... 500 mg CK-20173... | 18 Years - 80 Years | Cytokinetics | |
| Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis | NCT06414954 | Myasthenia Grav... Myasthenia Grav... | NMD670 Placebo | 18 Years - 75 Years | NMD Pharma A/S | |
| Physical Activity and Fatigue in Myasthenia Gravis | NCT03905473 | Myasthenia Grav... | Accelerometer m... | 18 Years - | Rigshospitalet, Denmark | |
| Feasibility of Engaging and Capturing Undiagnosed Myasthenia Gravis Participants Through a Social Media Campaign Paired With a Self-moderated Assessment | NCT06381284 | Myasthenia Grav... Neuromuscular M... Neuromuscular D... | Social media re... Self-Assessment Follow-up | 18 Years - | ZS Associates | |
| Perioperative Efgartigimod for Thymoma and Myasthenia Gravis | NCT06221501 | Myasthenia Grav... | Efgartigimod Al... | 18 Years - 75 Years | Shanghai Zhongshan Hospital | |
| Interleukin and Autoantibodies in Myasthenia Gravis. | NCT05301153 | Myasthenia Grav... | real time PCR ,... | 18 Years - 60 Years | Assiut University | |
| Thymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone Therapy | NCT00294658 | Myasthenia Grav... | thymectomy plus... prednisone alon... | 18 Years - 65 Years | University of Alabama at Birmingham | |
| Subcutaneous Immunoglobulin for Myasthenia Gravis | NCT04728425 | Myasthenia Grav... | subcutaneous im... intravenous imm... | 18 Years - 100 Years | University Health Network, Toronto | |
| A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding. | NCT06299748 | Myasthenia Grav... | Efgartigimod | 18 Years - | argenx | |
| Perception and Multisensory Integration in Neurological Patients Using fMRI | NCT01469858 | Acute Inflammat... Myasthenia Grav... Stroke Anosognosia Asomatognosia | Siemens magneto... | 18 Years - 80 Years | Hadassah Medical Organization | |
| A Pilot Trial of Rituxan in Refractory Myasthenia Gravis | NCT00619671 | Refractory Myas... | Rituximab (Ritu... | 18 Years - 80 Years | University of Vermont | |
| Acupuncture in Myasthenia Gravis (AcuMG) | NCT05230082 | Myasthenia Grav... | Acupuncture | 18 Years - 80 Years | HealthPartners Institute | |
| Safety, Tolerability and Immunogenic Response of CV-MG01 in Patients With Myasthenia Gravis | NCT02609022 | Myasthenia Grav... | CV-MG01 Placebo | 18 Years - 64 Years | CuraVac | |
| BeatMG: Phase II Trial of Rituximab In Myasthenia Gravis | NCT02110706 | Myasthenia Grav... | Rituximab Placebo | 21 Years - 90 Years | Yale University | |
| A Prospective Cohort Study of Myasthenia Gravis in China | NCT06006832 | Myasthenia Grav... | Steroid Drug Withdraw all im... | 18 Years - | Peking Union Medical College Hospital | |
| Pharmacodynamic Study of CK-2017357 in Patients With Generalized Myasthenia Gravis | NCT01268280 | Myasthenia Grav... | Placebo 250 mg CK-20173... 500 mg CK-20173... | 18 Years - 80 Years | Cytokinetics | |
| Immune Profiles in Myasthenia Gravis | NCT05095103 | Myasthenia Grav... | 18 Years - 80 Years | University of Manchester | ||
| The Impact of Myasthenia Gravis in the Real World | NCT04176211 | Myasthenia Grav... | 18 Years - | Vitaccess Ltd | ||
| Evaluate the Safety and Efficacy of CAR-T Cells in the Treatment of Refractory Myasthenia Gravis | NCT05828225 | Myasthenia Grav... | CD19 CAR-T cell... | 18 Years - | Zhejiang University | |
| A Pilot Study of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Generalized Myasthenia Gravis | NCT01555580 | Myasthenia Grav... | Granulocyte-Mac... | 18 Years - 80 Years | Muscular Dystrophy Association | |
| Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis | NCT02100969 | Myasthenia Grav... | HIZENTRA ® | 18 Years - | University of Kansas Medical Center | |
| Efficacy and Safety Study of GB-0998 for Treatment of Generalized Myasthenia Gravis | NCT00515450 | Generalized Mya... | GB-0998 (Intrav... Plasmapheresis | 16 Years - | Benesis Corporation | |
| An Open Study for Steroid Resistant, Non-Thymectomized MG Patients | NCT00309101 | Myasthenia Grav... | tacrolimus | 16 Years - 64 Years | Astellas Pharma Inc | |
| Study to Test the Safety, Tolerability and Efficacy of UCB7665 in Subjects With Moderate to Severe Myasthenia Gravis | NCT03052751 | Myasthenia Grav... | UCB7665 Placebo | 18 Years - | UCB Pharma | |
| Neurology Inpatient Clinical Education Trial | NCT03826056 | Myasthenia Grav... Guillain-Barre ... Multiple Sclero... Seizures Parkinsonism Meningitis Encephalitis Headache Vestibular Diso... Spondylosis Normal Pressure... | Current standar... Personalized di... | 18 Years - 95 Years | Dartmouth-Hitchcock Medical Center | |
| BeatMG: Phase II Trial of Rituximab In Myasthenia Gravis | NCT02110706 | Myasthenia Grav... | Rituximab Placebo | 21 Years - 90 Years | Yale University | |
| The Specificity, Sensitivity and Clinical Correlation of CBA, RIPA and ELISA in Detecting AChR and MuSK IgG of Myasthenia Gravis | NCT05219097 | Detection Autoa... | CBA Assay | 1 Year - 90 Years | Tianjin Medical University General Hospital | |
| A Prospective Cohort Study Of Myasthenia Gravis | NCT04674605 | Myasthenia Grav... Myasthenia Grav... | biomarkers | - 80 Years | First Affiliated Hospital of Chongqing Medical University | |
| Subcutaneous Immunoglobulin for Myasthenia Gravis | NCT04728425 | Myasthenia Grav... | subcutaneous im... intravenous imm... | 18 Years - 100 Years | University Health Network, Toronto |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
